Tumour transduction with NG2 shRNAs strongly reduced NG2 protein expression (Fig. 6H and I) and decreased cell proliferation compared to the control tumours (One-way ANOVA F9.259; df = 3; p = 0.0006; Fig. 6J). The gene discussed is CSPG4; the disease is neoplasm.